BioVie Inc. (BIVI)

BioVie Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Selling, General & Admin	8.79	11.55	9.77	4.64	1.31	1.26
Research & Development	29.35	33.3	17.26	133.19	1.15	1.01
Other Operating Expenses	0.23	0.23	0.23	0.23	0.23	0.23
Operating Expenses	38.37	45.08	27.25	138.05	2.69	2.5
Operating Income	-38.37	-45.08	-27.25	-138.05	-2.69	-2.5
Interest Expense / Income	3.56	4.3	2.16	0.56	4.77	0
Other Expense / Income	-5.64	0.88	-3.33	-8.36	9.21	-0.05
Pretax Income	-36.29	-50.26	-26.08	-130.25	-16.68	-2.44
Net Income	-36.29	-50.26	-26.08	-130.25	-16.68	-2.44
Preferred Dividends	0.89	0	0	53.6	17.1	0.05
Net Income Common	-37.18	-50.26	-26.08	-183.85	-33.78	-2.49
Shares Outstanding (Basic)	45	32	25	12	5	3
Shares Outstanding (Diluted)	45	32	25	12	5	3
Shares Change	26.82%	31.71%	98.84%	151.61%	94.10%	231.51%
EPS (Basic)	-0.94	-1.55	-1.06	-14.82	-6.85	-0.98
EPS (Diluted)	-0.94	-1.55	-1.06	-14.82	-6.85	-0.98
Free Cash Flow	-35.23	-40.25	-18.99	-10.45	-1.63	-2.5
Free Cash Flow Per Share	-0.79	-1.24	-0.77	-0.84	-0.33	-0.98
EBITDA	-32.5	-45.73	-23.69	-129.46	-11.67	-2.21
Depreciation & Amortization	0.23	0.23	0.23	0.23	0.23	0.23
EBIT	-32.73	-45.96	-23.92	-129.69	-11.9	-2.44

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).